Hydroxyzine Dosing for Pruritus and Anxiety
For pruritus, use hydroxyzine 25 mg three to four times daily in adults; for anxiety, use 50-100 mg four times daily in adults. 1
Pruritus Management
Adult Dosing
- Standard dose: 25 mg three to four times daily (TID or QID) for management of pruritus due to allergic conditions including chronic urticaria, atopic dermatitis, and contact dermatoses 1
- Hydroxyzine is particularly effective as a nighttime agent due to its sedative properties, which help patients sleep despite itching 2
- Non-sedating second-generation antihistamines should be used for daytime pruritus control, with hydroxyzine reserved for nighttime use 2
Pediatric Dosing for Pruritus
- Children under 6 years: 50 mg daily in divided doses 1
- Children over 6 years: 50-100 mg daily in divided doses 1
Special Considerations for Pruritus
- Reduce dose by 50% in moderate renal impairment (eGFR considerations) 2
- The British Association of Dermatologists supports hydroxyzine for generalized pruritus, noting significant improvement in symptoms and quality of life when used as nighttime medication 2
- If inadequate response occurs, consider increasing dose, adding H2 antihistamines, or switching to alternative treatments 2
Anxiety Management
Adult Dosing
- Standard dose: 50-100 mg four times daily (QID) for symptomatic relief of anxiety and tension associated with psychoneurosis 1
- Clinical trials demonstrate efficacy at fixed dose of 50 mg daily in generalized anxiety disorder, with superiority over placebo evident from the first week of treatment 3, 4
- Anxiolytic effects commence during the first week and are maintained throughout 4-week treatment periods without rebound anxiety or withdrawal symptoms upon abrupt discontinuation 4
Pediatric Dosing for Anxiety
- Children under 6 years: 50 mg daily in divided doses 1
- Children over 6 years: 50-100 mg daily in divided doses 1
Dosing Strategy to Minimize Side Effects
Evening or bedtime dosing (50 mg at bedtime) significantly reduces daytime sedation and psychomotor impairment while maintaining therapeutic efficacy 5
- This strategy maintains H1-receptor antagonism the following morning 5
- Alleviates reaction time prolongation seen with divided daytime doses 5
- Transient drowsiness typically appears during the first week but progressively diminishes with continued treatment 4
Critical Contraindications and Precautions
Absolute Avoidance
- Avoid in severe liver disease due to inappropriate sedating effects 2
- Contraindicated in early pregnancy 2
- Avoid in elderly patients with cognitive impairment due to anticholinergic effects 2
Common Side Effects
- Drowsiness (28% vs 14% placebo), typically transient 4
- Dry mouth (14% vs 5% placebo) 4
- Weight gain (12% vs 10% placebo) 4
- Loss of concentration (9% vs 8% placebo) 4
Dose Adjustment Algorithm
Adjust dosage according to patient response to therapy, as with all potent medications 1